iRhythm Holdings IRTC
Nasdaq · Surgical & Medical Instruments & Apparatus · $3.1BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $322.8M | $410.9M | $492.7M | $591.8M | $747.1M | +26.2% | +23.3% | |
| Cost of Revenue (COGS) | $109.3M | $129.3M | $160.9M | $184.3M | $219.9M | +19.3% | +19.1% | |
| Gross Profit | $213.6M | $281.6M | $331.8M | $407.5M | $527.3M | +29.4% | +25.3% | |
| Research & Development (R&D) | $38.7M | $46.6M | $60.2M | — | $60.2M | — | +11.7% | |
| Selling, General & Admin (SG&A) | $274.8M | $322.2M | $385.6M | $418.6M | $492.6M | +17.7% | +15.7% | |
| Total Operating Expenses | $313.5M | $395.4M | $457.0M | $523.0M | $584.7M | +11.8% | +16.9% | |
| Operating Income (EBIT) | $-99.9M | $-113.8M | $-125.2M | $-115.5M | $-57.4M | +50.3% | — | |
| Interest Expense | $1.2M | $4.1M | $3.6M | $12.8M | $13.2M | +2.6% | +83.2% | |
| Income Tax Expense | $367,000 | $269,000 | $750,000 | $565,000 | $953,000 | +68.7% | +26.9% | |
| GAAP Net Income | $-101.0M | $-116.0M | $-123.0M | $-113.0M | $-45.0M | +60.2% | — | |
| Diluted EPS | $-3.46 | $-3.88 | $-4.04 | $-3.63 | $-1.39 | +61.7% | — | |
| Diluted Shares | 29.3M | 29.9M | 30.5M | 31.2M | 32.0M | +2.6% | +2.2% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $127.6M | $78.8M | $36.2M | $428.0M | $244.4M | −42.9% | +17.6% | |
| Inventory | $10.3M | $15.2M | $14.0M | $14.0M | $21.6M | +54.1% | +20.5% | |
| Total Current Assets | $305.5M | $288.8M | $230.8M | $645.8M | $702.8M | +8.8% | +23.2% | |
| Total Assets | $463.0M | $448.2M | $433.1M | $931.4M | $1.0B | +9.5% | +21.8% | |
| Total Current Liabilities | $87.9M | $89.1M | $107.4M | $110.9M | $151.9M | +36.9% | +14.7% | |
| Total Debt (Short + Long Term) | $21.4M | $34.9M | $35.0M | $35.0M | $35.0M | +0.0% | +13.1% | |
| Total Liabilities | $183.5M | $208.4M | $223.0M | $840.5M | $867.3M | +3.2% | +47.5% | |
| Stockholders' Equity | $279.5M | $239.8M | $210.1M | $90.9M | $152.7M | +68.0% | −14.0% | |
| Net Cash / (Net Debt) | $106.2M | $43.9M | $1.2M | $393.0M | $209.4M | −46.7% | +18.5% | |
| Invested Capital | $173.3M | $195.9M | $208.9M | $-302.1M | $-56.7M | +81.2% | — | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $-37.8M | $-23.0M | $-50.1M | $3.4M | $80.9M | +2285.3% | — | |
| Depreciation & Amortization (D&A) | $9.8M | $13.4M | $16.3M | $20.7M | $20.7M | +0.0% | +20.6% | |
| Stock-Based Compensation (SBC) | $54.5M | $57.7M | $77.2M | $76.0M | $88.3M | +16.2% | +12.8% | |
| Capital Expenditures (CapEx) | $28.1M | $29.8M | $40.4M | $33.9M | $46.3M | +36.5% | +13.4% | |
| Free Cash Flow (FCF) | $-65.8M | $-52.8M | $-90.5M | $-30.6M | $34.5M | +213.0% | — | |
| True FCF (ex-SBC Owner Cash) | $-120.3M | $-110.6M | $-167.7M | $-106.5M | $-53.8M | +49.5% | — | |
| Share Repurchases (Buybacks) | — | $0 | $0 | $25.0M | $0 | −100.0% | — | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.